GLP-1 medications are also now being studied in individuals with metabolic liver disease, peripheral artery disease and neurodegenerative disorders, such as Alzheimers disease and Parkinsons disease
As GLP1 medicines have anorectic effects, the risk of using them must be carefully weighed against their potential benefits
So based on your risk factors and other things, your physician may choose other medications beyond just these shots and theres a lot of those out there now, much more than there was even 10 or so years ago. Dr
And its because GLP-1 has roles in the body, beyond its role in the management of glucose, that werent previously appreciated
The individual side effect rates (nausea, vomiting, diarrhea) are similar between the two compounds, but the discontinuation rate, which reflects how many people find the side effects intolerable, is significantly lower for semaglutide (5-7%) compared to retatrutide (12-18%)
In simple terms, retatrutide may help people eat less while also helping the body use energy more efficiently